为解决新冠疫情评估难题，研究人员开展 SARS-CoV-2 变异株与疫情关系研究，发现变异株可反映疫情特征，对监测预警有意义。 新冠疫情下的探索之旅：变异株监测的意义与挑战 新冠疫情自 2019 年 12 月爆发以来，深刻影响着全球。随着各国防控措施的逐步解除，新冠是否结束成为热议话题。从传染病流行病学角度看，繁殖数小于 1 常被视为疫情得到控制、接近尾声的标志。但如今新确诊病例数据不再被评估或报 ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...

The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and ...

本研究比较了常见冠状病毒（OC43、BoCoV）与SARS-CoV-2变体（WA-1、Delta、Omicron）在不同环境表面的持久性，发现它们存在显著差异，提示需谨慎使用替代病毒研究SARS-CoV-2的环境行为（SARS-CoV-2） 在抗击COVID-19的全球性挑战中，深入了解SARS-CoV-2在环境中的生存特性 ...

Early animal studies show that a single vaccine could protect the recipient from different variants of the coronaviruses that cause COVID-19, the flu and the common cold. In addition to creating ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...